NARA Discovery
Article Details
← Back to Search Results
Journal Article

Report of a novel missense TDP1 variant in a Pakistani family affected with an extremely rare disorder congenital spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1)

Riaz Ahmad; Filza Sayyad; Muhammad Naeem; Henry Houlden
Molecular Biology Reports · Vol. 52, Issue 1 · 2025

Abstract

Background Spinocerebellar ataxia with axonal neuropathy type 1 (OMIM: 607250) is an extremely rare autosomal recessive disorder caused by a mutation in the tyrosyl-DNA phosphodiesterase 1 ( TDP1) gene. Only a single missense variant (p.His493Arg) in this gene has been reported. This variant was found in three Arab families with a possible common founder effect. Methods and Results We report a female patient born to a consanguineous Pakistani family segregating autosomal recessive spinocerebellar ataxia with axonal neuropathy type 1. The patient presents additional clinical features distinct from previously reported Arab families including congenital onset of the disease. We performed whole exome sequencing with the patient’s DNA and identified a novel missense variant (NC_000014.9:g.89991982C > T; p.His478Tyr) in exon 13 of the TDP1 gene. Sanger sequencing was performed to verify the autosomal recessive segregation of the p.His478Tyr variant in the family. Conclusion The current study expands both the clinical and mutation spectrum of the TDP1 associated spinocerebellar ataxia with axonal neuropathy type 1 and increases the body of evidence that supports the pathogenic role of TDP1 in cerebellar ataxias with peripheral neuropathy.

Bibliographic Information

JournalMolecular Biology Reports
PublisherSpringer
Publication Date2025-12-01
Publication Year2025
Volume52
Issue1
Document TypeJournal Article
Print ISSN0301-4851
eISSN1573-4978
DOI10.1007/s11033-024-10085-8

Access Information

NARA Access Coverage1973-01-01~Current
Journal Homepagehttps://www.springer.com/journal/11033
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.